Patients should be able to access breakthrough dementia drugs on the NHS, head of a major social care review says
Baroness Casey said investment in dementia trials must also be urgently scaled up and suggested the disease is not given focus because it generally affects retired elderly people.
📰 Original Source
Read full article at Dailymail →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.